Error in Introduction

PMC · DOI:10.1001/jamanetworkopen.2025.4977·March 3, 2025

Error in Introduction

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Species1

Respiratory syncytial virus(no rank)

Chemicals1

RSVpreF

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsRespiratory viral infections research · COVID-19 Impact on Reproduction · Immunodeficiency and Autoimmune Disorders

Full text

In the Original Investigation titled “Respiratory Syncytial Virus and US Pediatric Intensive Care Utilization,”^1^ published October 25, 2024, the maternal RSVpreF vaccine was referred to by the wrong brand name; it should have been “Abrysvo.” This article has been corrected.^1^

Bibliography1

The reference list from the paper itself. Each links out to its DOI / PubMed record.

1Shanklin A, Olson T, Patel AK, Trujillo Rivera EA, Pollack MM. Respiratory syncytial virus and US pediatric intensive care utilization. JAMA Netw Open. 2024;7(10):e 2440997. doi:10.1001/jamanetworkopen.2024.4099739453655 PMC 11581606 · doi ↗ · pubmed ↗